Earnings Performance - Stratasys reported quarterly earnings of $0 01 per share, beating the Zacks Consensus Estimate of a loss of $0 02 per share, representing an earnings surprise of 150% [1] - The company's earnings per share (EPS) for the same quarter last year was $0 04 per share [1] - Over the last four quarters, the company has surpassed consensus EPS estimates two times [2] Revenue Performance - Stratasys posted revenues of $140 01 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 3 08% [2] - This compares to year-ago revenues of $162 13 million [2] - The company has not been able to beat consensus revenue estimates over the last four quarters [2] Stock Performance - Stratasys shares have lost about 41 3% since the beginning of the year, compared to the S&P 500's gain of 25 5% [3] - The stock's immediate price movement will depend on management's commentary on the earnings call [3] Earnings Outlook - The current consensus EPS estimate is $0 10 on $145 14 million in revenues for the coming quarter [7] - For the current fiscal year, the consensus EPS estimate is breakeven on $571 68 million in revenues [7] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions [5] Industry Outlook - The Zacks Industry Rank for Computer - Peripheral Equipment is currently in the bottom 39% of the 250 plus Zacks industries [8] - The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8] Peer Performance - Dragonfly Energy Holdings Corp (DFLI) is expected to post a quarterly loss of $0 18 per share, representing a year-over-year change of -5 9% [9] - The company's revenues are expected to be $14 12 million, down 11 1% from the year-ago quarter [10] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days [9]

Stock Performance - Stratasys shares ended the last trading session 9 9% higher at $7 70, with a higher-than-average trading volume [1] - The stock had previously experienced a 13 9% loss over the past four weeks [1] - Immersion (IMMR), another stock in the same industry, closed the last trading session 2% higher at $8 83, but has returned -3 2% over the past month [3] Financial Expectations - Stratasys is expected to post a quarterly loss of $0 02 per share, representing a year-over-year change of -150% [2] - Revenues for Stratasys are expected to be $144 45 million, down 10 9% from the year-ago quarter [2] - Immersion's consensus EPS estimate for the upcoming report has remained unchanged at $0 15, representing a year-over-year change of +87 5% [4] Industry and Company Factors - Stratasys shares are benefiting from increased demand for 3D printed equipment, strategic partnerships, and expansion of product offerings [1] - Organizational restructuring and cost-minimizing strategies are also contributing to the positive performance of Stratasys stock [1] - Stratasys belongs to the Zacks Computer - Peripheral Equipment industry, and both Stratasys and Immersion currently carry a Zacks Rank of 3 (Hold) [3][4] Earnings Estimate Trends - The consensus EPS estimate for Stratasys has remained unchanged over the last 30 days [3] - Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements [2] - The stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions [3]

Performance and Market Comparison - Stratasys (SSYS) shares have plunged 47.7% year to date, underperforming the Zacks Computer and Technology Sector (up 19.4%) and the Zacks Computer-Peripheral Equipment Industry (down 27.4%) [1] - SSYS has lagged behind peers like Mercury Systems (MRCY, up 0.7%), Immersion (IMMR, up 25.6%), and TransAct Technologies (TACT, down 38%) [1] Financial Results - Total revenues for the first half of 2024 declined 8.8% year over year to $282 million [1] - Product revenues were $192 million (down 8.2%), and service revenues were $89 million (down 9.8%) [1] - The Zacks Consensus Estimate for third-quarter 2024 revenues is $152.6 million, indicating a year-over-year decline of 5.9% [3] - The Zacks Consensus Estimate for 2024 revenues is $570 million, indicating a year-over-year decline of 9.18% [3] Earnings Outlook - The Zacks Consensus Estimate for third-quarter 2024 earnings is 2 cents, down 71.4% over the past 30 days [2] - The consensus mark for full-year 2024 earnings is 5 cents per share, down 64.3% over the past 30 days [2] Challenges and Risks - High interest rates, macroeconomic uncertainties, and reduced capital equipment spending have negatively impacted Stratasys' results [1] - Delayed purchases and longer sales cycles are expected to continue affecting second-half 2024 results [2] Growth Opportunities - The global 3D printing market is estimated to grow from $17.5 billion in 2024 to $37.4 billion by 2029, increasing by 16.4% annually [4] - Stratasys has introduced newer 3D printing technology and partnered with AM Craft to maximize additive manufacturing benefits [4] - The company recently enrolled a patient in a clinical study to analyze the efficacy of 3D-printed models for orthopedic oncology [4] Strategic Initiatives - Stratasys plans to reduce its workforce by 15% to mitigate macroeconomic volatility [5] - The company aims to achieve an EBITDA margin of 8% at current revenue levels by the first quarter of 2025 [5] Valuation and Ranking - Stratasys currently has a Zacks Rank 4 (Sell), suggesting investors should avoid the stock [6] - The Value Score of D indicates a stretched valuation [6]

Financial Performance - Stratasys reported a loss of 4 cents per share in Q2 2024, in line with the Zacks Consensus Estimate, compared to non-GAAP earnings of 4 cents per share in the year-ago quarter [1] - Quarterly revenues declined 13.6% YoY to $138 million, missing the consensus mark by 6.78%, partially due to divestitures and unfavorable foreign currency exchange rates [1] - Non-GAAP gross profit fell 9.8% YoY to $67.7 million, while the non-GAAP gross margin expanded 50 bps to 49% [2] - Non-GAAP operating expenses decreased 2.2% YoY to $70.9 million, resulting in a non-GAAP operating loss of $3.2 million, compared to a profit of $5 million in the year-ago quarter [2] - Adjusted EBITDA plunged 78.3% YoY to $2.3 million [2] Segment Performance - Product revenues declined 14.2% YoY to $93.6 million, with System revenues plunging 40% YoY to $29 million, while Consumables revenues increased 6.3% YoY to $64.6 million [2] - Services revenues declined 12.2% YoY to $44.4 million, with Customer Support revenues advancing 3.8% YoY to $30.5 million [2] Strategic Developments - Stratasys solidified a partnership with AM Craft to support additive manufacturing of EASA-certified aircraft sustainment parts, opening new opportunities in the aviation sector [3] - The company launched new products, including SAF High-Def printing capabilities, H350 version 1.5, and SAF Polypropylene material, expanding manufacturing applications and use cases [3] - Stratasys software offerings, including GrabCAD Print Pro and GrabCAD Streamline Pro, showed strong demand, with Print Pro expanding to PolyJet users and Streamline Pro gaining traction [3] Balance Sheet & Cash Flow - Stratasys ended Q2 with cash and short-term deposits of $150.9 million, down from $161.1 million at the end of the previous quarter [4] - The company reported a negative operating cash flow of $2.4 million, a significant decline from the positive operating cash flow of $7.3 million in the previous quarter [4] 2024 Outlook - Management lowered 2024 revenue projections to $570-$580 million, down from the previous forecast of $630-$645 million [5][6] - Non-GAAP earnings per share are now forecasted at 1-5 cents, compared to the previous range of 12-19 cents [5][6] - Gross margins are expected to be between 48.7% and 49%, down from the previous range of 49%-49.5% [5][6] - Non-GAAP operating margin is projected at 0.5%-1%, compared to the previous range of 2.5%-3.5% [5][6] - Operating expenses are estimated at $276-$278 million, down from the previous range of $292-$297 million [5][6] - Adjusted EBITDA is projected at $24-$27 million, down from the previous range of $40-$45 million [5][6] Stock Performance - Stratasys' shares have plunged 51.5% year-to-date, underperforming the Zacks Computer & Technology sector's rise of 20.3% [6]

Stratasys Ltd. SSYS reported worse-than-expected second-quarter sales and cut its FY24 guidance on Thursday.Stratasys reported fiscal second-quarter 2024 revenue of $138.04million, missing the analyst consensus estimate of $146.34 million. Adjusted EPS loss of 4 cents beat the analyst consensus estimate of 5 cent loss.The company shared plans to downsize its workforce by 15% by 2024 end to save $40 million in annual cost beginning in the first quarter of 2025, along with annualized EBITDA margins of 8%.Stra ...

Stratasys stock is 3D printing nothing but losses these days.Stratasys (SSYS -14.71%) stock fell 14.9% through 12:05 p.m. on mixed earnings on Thursday.Wall Street analysts had forecast the 3D printing company would lose $0.05 per share in the second quarter, and the good news is that Stratasys beat that estimate -- losing "only" $0.04. The bad news is that Stratasys fell well short of Street forecasts for $146.3 million in Q2 sales, reporting only $138 million. Stratasys' Q2 earningsThis news gets worse. T ...

Stratasys Ltd. (NASDAQ:SSYS) Q2 2024 Earnings Conference Call August 29, 2024 8:30 AM ET Company Participants Yonah Lloyd - Chief Communications Officer and VP, IR Yoav Zeif - CEO Eitan Zamir - CFO Conference Call Participants Greg Palm - Craig Hallum James Ricchiuti - Needham & Company Troy Jensen - Cantor Fitzgerald Jacob Stephan - Lake Street Capital Markets Brian Drab - William Blair Ananda Baruah - Loop Capital Markets Operator Hello, and welcome to the Stratasys’ Q2 2024 Earnings Call and Webcast. At ...

Stratasys (SSYS) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this maker of 3D printers would post a loss of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of 50%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Stratasys, which belongs to the Za ...

Stratasys (SSYS) is slated to release second-quarter 2024 results on Aug. 29.The Zacks Consensus Estimate for Stratasys’ second-quarter revenues is pegged at $148.08 million, indicating a year-over-year decrease of 7.31%. The consensus mark for the bottom line is pegged at a loss of 4 cents per share. SSYS posted non-GAAP earnings of 4 cents per share in the year-ago quarter.Its earnings beat the Zacks Consensus Estimate twice in the trailing four quarters, matched once and missed once, the average surprise ...

Core Viewpoint - The collaboration between CollPlant Biotechnologies and Stratasys aims to develop 3D printed breast implants that can regenerate natural breast tissue and degrade over time, addressing a $3 billion market opportunity in the breast implant sector [1][2][3]. Company Overview - CollPlant is focused on regenerative and aesthetic medicine, utilizing its proprietary rhCollagen technology for tissue regeneration and organ manufacturing [8]. - Stratasys is a leader in polymer 3D printing solutions, providing innovative technologies across various industries, including healthcare [6][8]. Market Opportunity - The global breast implant market is estimated at $3 billion, with breast reconstruction and augmentation being among the most common plastic surgery procedures worldwide [3]. - CollPlant's implants are designed to provide a revolutionary alternative to traditional silicone implants, which carry risks of complications [2][3]. Technological Development - The pre-clinical study will test the implants' ability to promote natural tissue growth and biodegradation, marking a significant advancement in regenerative medicine [1][2]. - Stratasys has adapted its Origin printer to produce the 200cc regenerative implants, with initial study results expected in the first half of 2025 [3][4]. Safety and Efficacy - Previous pre-clinical studies indicated positive outcomes, including well-developed connective tissue and initial biodegradation of the implants, confirming their safety profile [4].